ARCHIVES

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

NCI director recognizes work of staff.

October 17, 2003

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

Pitot Named New NCAB Chairman

May 4, 1979